CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $66,254,230 | +29.9% | 1,222,854 | +68.1% | 0.01% | +22.2% |
Q1 2024 | $51,001,450 | -40.0% | 727,449 | -28.5% | 0.01% | -43.8% |
Q4 2023 | $84,954,748 | +306.5% | 1,017,544 | +43.4% | 0.02% | +300.0% |
Q3 2023 | $20,900,397 | -42.1% | 709,450 | -35.9% | 0.00% | -50.0% |
Q2 2023 | $36,085,483 | -4.6% | 1,106,238 | +3.0% | 0.01% | -11.1% |
Q1 2023 | $37,812,500 | -9.3% | 1,074,524 | +18.0% | 0.01% | -10.0% |
Q4 2022 | $41,707,700 | +126852.5% | 910,251 | +34.2% | 0.01% | +25.0% |
Q3 2022 | $32,853 | +77.6% | 678,084 | +44.0% | 0.01% | +60.0% |
Q2 2022 | $18,496 | -99.9% | 470,753 | -28.8% | 0.01% | 0.0% |
Q1 2022 | $24,347,000 | -4.4% | 661,446 | +18.4% | 0.01% | 0.0% |
Q4 2021 | $25,466,000 | -27.6% | 558,704 | -43.2% | 0.01% | -28.6% |
Q3 2021 | $35,184,000 | +216.1% | 984,465 | +75.0% | 0.01% | +250.0% |
Q2 2021 | $11,132,000 | -40.6% | 562,503 | -30.1% | 0.00% | -60.0% |
Q1 2021 | $18,731,000 | +9.4% | 805,288 | -2.2% | 0.01% | +25.0% |
Q4 2020 | $17,118,000 | -21.4% | 823,764 | -18.1% | 0.00% | -42.9% |
Q3 2020 | $21,782,000 | +13.4% | 1,006,131 | +23.5% | 0.01% | +16.7% |
Q2 2020 | $19,201,000 | +237.6% | 814,639 | +68.9% | 0.01% | +200.0% |
Q1 2020 | $5,687,000 | +63.7% | 482,349 | +47.4% | 0.00% | +100.0% |
Q4 2019 | $3,473,000 | +121.5% | 327,302 | +137.7% | 0.00% | – |
Q3 2019 | $1,568,000 | +35.8% | 137,704 | +34.1% | 0.00% | – |
Q2 2019 | $1,155,000 | -39.7% | 102,672 | -56.6% | 0.00% | -100.0% |
Q1 2019 | $1,916,000 | +79.2% | 236,829 | +40.0% | 0.00% | – |
Q4 2018 | $1,069,000 | -31.4% | 169,187 | +7.0% | 0.00% | – |
Q3 2018 | $1,558,000 | -37.2% | 158,159 | -47.0% | 0.00% | -100.0% |
Q2 2018 | $2,479,000 | -2.8% | 298,651 | -15.7% | 0.00% | 0.0% |
Q1 2018 | $2,551,000 | -25.0% | 354,263 | -15.2% | 0.00% | 0.0% |
Q4 2017 | $3,403,000 | -40.5% | 417,597 | +5.8% | 0.00% | 0.0% |
Q3 2017 | $5,721,000 | +65.3% | 394,566 | +38.0% | 0.00% | 0.0% |
Q2 2017 | $3,461,000 | +423.6% | 286,018 | +456.1% | 0.00% | – |
Q1 2017 | $661,000 | -23.9% | 51,430 | -28.1% | 0.00% | – |
Q4 2016 | $869,000 | -40.9% | 71,491 | -55.4% | 0.00% | – |
Q3 2016 | $1,470,000 | +50.6% | 160,162 | +55.7% | 0.00% | – |
Q2 2016 | $976,000 | +162.4% | 102,839 | +189.2% | 0.00% | – |
Q4 2015 | $372,000 | +244.4% | 35,554 | +120.4% | 0.00% | – |
Q3 2015 | $108,000 | -89.8% | 16,134 | -89.7% | 0.00% | – |
Q2 2015 | $1,055,000 | +0.8% | 157,035 | +1.7% | 0.00% | – |
Q1 2015 | $1,047,000 | -53.1% | 154,340 | -44.6% | 0.00% | – |
Q4 2014 | $2,232,000 | +717.6% | 278,652 | +259.7% | 0.00% | – |
Q3 2014 | $273,000 | +7.1% | 77,470 | +45.6% | 0.00% | – |
Q2 2014 | $255,000 | -96.0% | 53,197 | -92.0% | 0.00% | -100.0% |
Q1 2014 | $6,327,000 | +7808.8% | 666,027 | +6193.4% | 0.00% | – |
Q3 2013 | $80,000 | – | 10,583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |